922 related articles for article (PubMed ID: 26125718)
21. Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia.
Wang H; Yan H; Wang Z; Zhu L; Liu J; Guo Z
Pediatrics; 2012 Jun; 129(6):e1612-5. PubMed ID: 22566416
[TBL] [Abstract][Full Text] [Related]
22. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia].
Chen HR; Lou JX; Zhang Y; Liu XD; Yang K; Chen P; Liu B; He XP; Guo Z; Liu D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):959-64. PubMed ID: 22931664
[TBL] [Abstract][Full Text] [Related]
25. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.
Bacigalupo A; Locatelli F; Lanino E; Marsh J; Socié G; Maury S; Prete A; Locasciulli A; Cesaro S; Passweg J;
Bone Marrow Transplant; 2005 Dec; 36(11):947-50. PubMed ID: 16205733
[TBL] [Abstract][Full Text] [Related]
26. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
[TBL] [Abstract][Full Text] [Related]
27. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
28. [The efficacy and safety of mismatched hematopoietic stem cell transplantation for treatment of severe aplastic anemia].
Han W; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Chen YH; Wang FR; Wang Y
Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):287-90. PubMed ID: 21600145
[TBL] [Abstract][Full Text] [Related]
29. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Sedlácek P; Formánková R; Keslová P; Srámková L; Hubácek P; Król L; Kulich M; Starý J
Bone Marrow Transplant; 2006 Dec; 38(11):745-50. PubMed ID: 17041606
[TBL] [Abstract][Full Text] [Related]
30. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
31. [Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy].
Chen Y; Zhang XH; Xu LP; Liu KY; Qin J; Yang YL; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):409-413. PubMed ID: 31209410
[TBL] [Abstract][Full Text] [Related]
32. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
33. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
34. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
[TBL] [Abstract][Full Text] [Related]
35. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
36. [Haploidentical hematopoietic stem cell transplantation for the treatment of severe aplastic anemia in children].
Liu Y; Tang SQ; Huang WR; Li HH; Zhao Y; Bo J; Zhang N; Wang F; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):985-9. PubMed ID: 23998598
[TBL] [Abstract][Full Text] [Related]
37. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
[TBL] [Abstract][Full Text] [Related]
38. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
39. Transplant in Aplastic Anemia Using Combined Granulocyte Colony-Stimulating Factor Primed Blood and Bone Marrow Stem Cells: A Retrospective Analysis.
Ali N; Butt A; Altaf B; Adil SN; Shaikh MU
Transplant Proc; 2021; 53(1):386-390. PubMed ID: 32773285
[TBL] [Abstract][Full Text] [Related]
40. Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic.
Wang H; Wang Z; Xue M; Liu J; Yan H; Guo Z
Cytotherapy; 2010 Jul; 12(4):563-5. PubMed ID: 20380540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]